{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05363865",
            "orgStudyIdInfo": {
                "id": "390234"
            },
            "organization": {
                "fullName": "University of Pennsylvania",
                "class": "OTHER"
            },
            "briefTitle": "Digital Community to Improve Health in Rural Areas",
            "officialTitle": "Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia",
            "therapeuticArea": [
                "Infectious Diseases",
                "Gastroenterology"
            ],
            "study": "digital-community-to-improve-health-in-rural-areas"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-21",
            "studyFirstSubmitQcDate": "2022-05-02",
            "studyFirstPostDateStruct": {
                "date": "2022-05-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Pennsylvania",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.",
            "detailedDescription": "The study will randomize clusters with groups of participants to an intervention or a standard of care condition."
        },
        "conditionsModule": {
            "conditions": [
                "HIV Infections",
                "Hepatitis C Virus Infection"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "FACTORIAL",
                "interventionModelDescription": "Clusters will be randomized to either the intervention or the standard of care.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "The outcomes assessor will be unaware of the experimental condition.",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 600,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Virtual Community Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will participate in an online community with structured sessions as well as the ability to communicate freely with others.",
                    "interventionNames": [
                        "Behavioral: Virtual Community Intervention"
                    ]
                },
                {
                    "label": "Standard of Care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will be exposed to what's disseminated within their communities",
                    "interventionNames": [
                        "Behavioral: Standard of Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Virtual Community Intervention",
                    "description": "Modules of community building, HIV/HCV prevention, drug and service stigma, identification of mental health problems",
                    "armGroupLabels": [
                        "Virtual Community Intervention"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Standard of Care",
                    "description": "health websites and county information provided to participants",
                    "armGroupLabels": [
                        "Standard of Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "HIV/HCV Testing and Treatment",
                    "description": "Measures:\n\nTest for HIV Receive HIV treatment if HIV positive If they test positive for HIV, receive referral to HIV treatment. Self-report of receiving referral of HIV treatment.\n\nTest for HCV Receive HCV treatment if HCV positive If they test positive for HCV, receive referral to HCV treatment. Self-report of receiving referral of HCV treatment.\n\nSeeking treatment for HIV/HCV if they test positive\n\nBinary (Yes/No)",
                    "timeFrame": "Baseline [Control not offered testing at baseline], Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "HIV/HCV Prevention",
                    "description": "Measures:\n\nIf they have HIV risk, using PrEP (Pre-Exposure Prophylaxis)\n\nBinary (Yes/No)\n\nUse a condom when you had sex\n\nContinuous (Numeric)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Overdose Prevention",
                    "description": "Measures:\n\nIf your state allows it, would you like us to send you Narcan/naloxone?\n\nBinary (Yes/No)\n\nCarry Naloxone Frequency\n\nScale (Never; Sometimes; Often; Always)",
                    "timeFrame": "Baseline[Control not offered Naloxone at baseline], Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Seeking Mental/Physical Health Treatment",
                    "description": "Measures:\n\nSee a mental health professional if there concerns or substance use Attend a 12-step group if previous substance use Attend another abstinence-based program if previous substance use Attend a substance use treatment program that uses medications if previous substance use Attend a faith-based substance use group\n\nBinary (Yes/No)\n\nResearch team reported referrals provided to participants healthcare and mental health/substance use recovery.\n\nContinuous (Numeric)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Stigmatizing Language",
                    "description": "Measures:\n\nRefrain from using hurtful language to refer to people with substance use disorder Refrain from using hurtful language to refer to people from other groups (e.g., religious) Intend to say something to intervene when someone uses hurtful language\n\nScale (Never; Sometimes; Almost Always; Always)\n\nPeople who use drugs are to blame for their drug use. People who use drugs are dangerous. People who use drugs should be excluded from society. People with a mental health condition are to blame for their condition. People with a mental health condition are dangerous. People with a mental health condition should be excluded from society.\n\nScale (Strongly disagree; somewhat disagree; neither disagree not agree; somewhat agree; strongly agree)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Social Connections",
                    "description": "Measures:\n\nHow many new social connections were established (since the beginning of the study)? How many of the new social connections established since the beginning of the study are you still in touch with? How many old social connections were re-established (since the beginning of the study)? How many re-established social connections established since the beginning of the study are you still in touch with? How many people in your life who can do a favor for you (lend you money, run an errand)? How many people in your life can support you if you are sad, worried, or frustrated?\n\nContinuous (Numeric)\n\nHave you (did you) joined/join organizations, groups, activities (since the beginning of the study)?\n\nBinary (Yes/No)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Substance Use",
                    "description": "Measures:\n\nUse substance without a prescription or more than prescribed Inject substances\n\nScale (Never; A few times but not in the past year Once a month; A few times a month Once a week; A few times a week Once a day; More than once a day)\n\nDrink alcohol frequency\n\nScale (Never; A few times but not in the past year Once a month; A few times a month Once a week; A few times a week Once a day; More than once a day)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Syringe Use",
                    "description": "Measures:\n\nIf using injection drugs:\n\nUsing syringe services (e.g., exchange) Disinfect injection equipment Use someone else's syringe\n\nBinary (Yes/No)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Policy Support",
                    "description": "Measures:\n\nThe government should punish people for using illicit drugs or drugs without a prescription To prevent the spread of disease, the government should provide clean syringes for people who inject drugs as a way of avoiding infections The government should pay for treatment for drug addiction when community members need treatment The government should provide free treatment for infections that result from drug use The government should jail people who use drugs illegally. The government should deal with drug misuse by supporting the use of medication that reduces addiction.\n\nThe government should deal with drug misuse by funding drug treatment programs that help people out of addiction.\n\nScale (Strongly disagree; somewhat disagree; neither disagree not agree; somewhat agree; strongly agree)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Using Naloxone on Someone",
                    "description": "Use of Naloxone to prevent overdose for another.\n\nBinary (Yes/No)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Contributions to town, neighborhood, community of friends, church, or other groups",
                    "description": "Have you contributed to your town, neighborhood, community of friends, church, or other groups (including people with whom you interact in this study) (since the beginning of the study)?\n\nScale (Not at all; A little; Somewhat; A lot; A great deal)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                },
                {
                    "measure": "Discovering new organizations, groups, or activities",
                    "description": "Have you found out (did you) find out about organizations, groups, activities to join (since the beginning of the study)?\n\nScale (Not at all; A little; Somewhat; A lot; A great deal)",
                    "timeFrame": "Baseline, Session 2 [Experimental Condition Only], Immediate Follow-Up (3 Weeks), 3 months, 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Lives in target zip codes\n* Half not using illicit substances (not including marijuana) currently or in the past\n* Half using illicit substances (not including marijuana) currently or in the past\n\nExclusion Criteria:\n\n* Under the age of 18\n* Not in target zip codes",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Dolores Albarracin, PhD",
                    "role": "CONTACT",
                    "phone": "2178402383",
                    "email": "dalba@upenn.edu"
                },
                {
                    "name": "Christopher J Quasti, PhD",
                    "role": "CONTACT",
                    "email": "Cquasti@upenn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dolores Albarracin, PhD",
                    "affiliation": "Univ. of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dolores Albarracin, Ph.D.",
                            "role": "CONTACT",
                            "phone": "217-840-2383",
                            "email": "dalba@upenn.edu"
                        },
                        {
                            "name": "Dolores Albarracin, Ph.D",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000006526",
                    "term": "Hepatitis C"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000006505",
                    "term": "Hepatitis"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000086982",
                    "term": "Blood-Borne Infections"
                },
                {
                    "id": "D000006525",
                    "term": "Hepatitis, Viral, Human"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000018178",
                    "term": "Flaviviridae Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M9592",
                    "name": "Hepatitis A",
                    "relevance": "LOW"
                },
                {
                    "id": "M9591",
                    "name": "Hepatitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9611",
                    "name": "Hepatitis C",
                    "asFound": "Hepatitis C Virus Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2593",
                    "name": "Blood-Borne Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M9610",
                    "name": "Hepatitis, Viral, Human",
                    "relevance": "LOW"
                },
                {
                    "id": "M20324",
                    "name": "Flaviviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}